Over-expression of EPHA2 in tandem with a diminished engagement with the EFNA1 ligand can lead to increased motility and invasive properties of tumor cells which is consistent with a pro-metastatic phenotype [10]. The gene discussed is EPHA2; the disease is neoplasm.